Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
dario.vizza@uniroma1.it
Carmine Dario Vizza
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
dario.vizza@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
MEDICINA
2022
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION
2022
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
EUROPEAN RESPIRATORY REVIEW
2022
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - an analysis of FREEDOM-EV
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION
2022
Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients
EUROPEAN HEART JOURNAL SUPPLEMENTS
2022
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension
JACC. CARDIOVASCULAR IMAGING
2021
The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece
JOURNAL OF CLINICAL MEDICINE
2021
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up
JOURNAL OF CLINICAL MEDICINE
2021
Pulmonary vascular resistance in pulmonary arterial hypertension. la piece de resistance. reply
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2021
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE). a multicentre, open-label, randomised controlled trial
THE LANCET RESPIRATORY MEDICINE
2021
Pulmonary hypertension in patients with COPD. results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)
CHEST
2021
Medical treatment of pulmonary hypertension in adults with congenital heart disease. updated and extended results from the International COMPERA-CHD registry
CARDIOVASCULAR DIAGNOSIS AND THERAPY
2021
Right ventricular assessment matters for precision medicine. Reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE"
INTERNATIONAL JOURNAL OF CARDIOLOGY
2021
COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension
EUROPEAN RESPIRATORY JOURNAL
2021
ECMO Assistance during Mechanical Ventilation. effects Induced on energetic and haemodynamic variables
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension. final safety data from the EXPERT registry
RESPIRATORY MEDICINE
2021
Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china
INTERNATIONAL JOURNAL OF CARDIOLOGY
2021
Right ventricular strain in pulmonary hypertension looking at the small print reply
JACC. CARDIOVASCULAR IMAGING
2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution): proposal of a study protocol aimed to realize a validated risk score for early diagnosis
MINERVA CARDIOLOGY AND ANGIOLOGY
2021
« prima
< precedente
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
A computational model to simulate the hemodynamic effects of right ventricular failure in patients with pulmonary arterial hypertension
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma